Add BrightSurf on Google Email

Victor Chang Cardiac Research Institute


New study uncovers how genetics and lifestyle drive the heart disease dilated cardiomyopathy

Researchers found that individuals with a mutation in the TTN gene are 21 times more likely to develop dilated cardiomyopathy than those without. Lifestyle factors such as being overweight or having high alcohol consumption contribute to an earlier diagnosis, and men with the mutation are more likely to develop DCM at a younger age.

SourceVictor Chang Cardiac Research Institute·JournalEuropean Heart Journal·TypeObservational study·DateAug 11, 2025

Olympians' hearts in focus: groundbreaking study reveals elite rowers' surprising AFib risk

A new study involving 121 former elite rowers from Australia found that one in five develops atrial fibrillation, a condition that can lead to stroke and heart failure. The researchers identified genetic and clinical tools that enable early preventive strategies, highlighting the paradox that AFib is more common among fit athletes.

SourceVictor Chang Cardiac Research Institute·JournalEuropean Heart Journal·TypeObservational study·DateJun 25, 2025

World's first individual gene mutation test for predicting risk of sudden cardiac death

A new individualized risk prediction tool has been developed to predict the severity of heart disease in people suffering from Long QT syndrome. The test analyzes genetic mutations associated with the condition and can identify those at high risk of sudden cardiac death, allowing for tailored treatment.

SourceVictor Chang Cardiac Research Institute·JournalCirculation·TypeData/statistical analysis·DateSep 25, 2024

Do genes that code athletic heart enlargement carry a risk of future heart problems?

A new study found that one in six elite athletes have reduced heart function and an enrichment of genes associated with heart muscle disease. The research highlights the need for closer monitoring of these athletes' heart health, as their genetic makeup may be 'stressed' by exercise to cause profound heart changes.

SourceVictor Chang Cardiac Research Institute·JournalCirculation·TypeObservational study·DateDec 18, 2023

Molecule identified that could be key for a new wave of drugs to target obesity and bone diseases

Scientists have identified a molecule that regulates nerve cell sensors, which could lead to new therapeutics for obesity, osteoporosis, and inflammatory diseases. The molecule can be modified into peptide-based therapeutics to boost the activity of channels involved in bone strength and satiety.

SourceVictor Chang Cardiac Research Institute·JournalScience·TypeExperimental study·DateAug 17, 2023